To maximize the commercial potential of our technology, Intarcia continues to evaluate new opportunities for novel and proprietary product candidates, with efforts focused around two areas:

  • Evaluation of new applications of our drug delivery technology to develop products for which we can hold exclusive development and commercialization rights; and
  • Exploration of collaborative opportunities with partners to which our formulation and drug delivery technology and expertise can lend enhancement of life-cycle management, product line extension or a competitive edge.

To learn more about Intarcia's partnering opportunities or accessing Intarcia's formulation and delivery technology platform, please contact Intarcia Business Development at

Our Pipeline

Gaining better control of type 2 diabetes is the Company’s first therapeutic goal. Diabetes has reached epidemic proportions in many developed countries.